Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer

Journal of Gene Medicine

Volumn 14, Issue 2, 2012, Pages 120-127

  Hamada, Katsuyuki ^a   Yoshihara, Chieko ^b   Ito, Tomoko ^c   Tani, Kenzaburo ^d   Tagawa, Masatoshi ^e   Sakuragawa, Norio ^f   Itoh, Hiroshi ^g   Koyama, Yoshiyuki ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OTSUMA WOMEN'S UNIVERSITY   (Japan)

^c MUSASHINO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY HOSPITAL   (Japan)

^e CHIBA CANCER CENTER   (Japan)

^f Bioresource Application Institute   (Japan)

^g TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Cancer gene therapy; Chondroitin sulfate; Hyaluronic acid; Ovarian cancer; Polyethyleneimine; Ternary plasmid complex: GM CSF

Indexed keywords

CHONDROITIN SULFATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; PLASMID VECTOR; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG COATING; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHONDROITIN SULFATES; FEMALE; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; HUMANS; HYALURONIC ACID; KAPLAN-MEIER ESTIMATE; MICE; OVARIAN NEOPLASMS; PLASMIDS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 84857170293     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1647     Document Type: Article

References (25)

1. Hamada K, Desaki J, Nakagawa K, et al. Carrier cell-mediated infection of a replication-competent adenovirus for cancer gene therapy. Mol Ther 2007; 15: 1121-1128.
2. Plank C, Mechtler K, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 12: 1437-1446.
3. Maruyama K, Iwasaki F, Takizawa T, et al. Novel receptor-mediated gene delivery system comprising plasmid/protamine/sugar-containing polyanion ternary complex. Biomaterials 2004; 16: 3267-3273.
4. Koyama Y, Yamada E, Ito T, Mizutani Y, Yamaoka T. Plasmid/polycation complexes for receptor-mediated gene delivery. Macromol Biosci 2002; 2: 251-256.
5. Finsinger D, Remy JS, Erbacher P, Koch C, Plank C. Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther 2000; 7: 1183-1192.
6. Ito T, Iida-Tanaka N, Niidome T, et al. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release 2006; 112: 382-388.
7. Koyama Y, Yamashita M, Iida-Tanaka N, Ito T. Enhancement of transcriptional activity of DNA complexes by amphoteric PEG derivative. Biomacromolecules 2006; 7: 1274-1279.
8. Sakae M, Ito T, Yoshihara C, et al. Highly efficient in vivo gene transfection by plasmid/PEI complexes coated by anionic PEG derivatives bearing carboxyl groups and RGD peptide. Biomed Pharmacother 2008; 62: 448-453.
9. Ito T, Iida-Tanaka N, Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J Drug Target 2008; 16: 276-281.
10. Trubetskoy VS, Loomis A, Slattum PM, Hagstrom JE, Budker VG, Wolff JA. Caged DNA does not aggregate in high ionic strength solutions. Bioconjug Chem 1999; 10: 624-628.
11. Ito T, Yoshihara C, Hamada K, Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 2010; 31: 2912-2918.
12. Sugahara KN, Hirata T, Tanaka T, et al. Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells. Cancer Res 2008; 68: 7191-7199.
13. Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest 1996; 97: 2541-2452.
14. Hirabayashi Y, Marugame T. Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol 2009; 39: 860-861.
15. Grzybowski J, Oldak E, Antos-Bielska M, Janiak MK, Pojda Z. New cytokine dressing kinetics of the in vitro rhG-CSF, rhGM-CSF, and rhEGF release from the dressings. Int J Pharm 1999; 184: 173-178.
16. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Imunol 2008; 8: 533-544.
17. Bradbury PA, Shepherd FA. Immunotherapy for lung cancer. J Thorac Oncol 2008; 3: 164-170.
18. Holt GE, Disis ML. Immune modulation as a therapeutic strategy for non-small-cell lung cancer. Clin Lung Cancer 2008; 9: 13-19.
19. Nour El-Din AN, Shkareta L, Talbot BG, Diarra MS, Lacasse P. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus. Vaccine 2006; 24: 1997-2006.
20. Sezer AD, Akbuga J. Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics. AAPS PharmSciTeck 2009; 10: 1193-1199.
21. Guilherme MR, Reis AV, Alves BRV, Kunita MH, Rubira AF, Tambourgi EB. Smart hollow microspheres of chondroitin sulfate conjugates and magnetite nanoparticles for magnetic vector. J Colloid Int Sci 2010; 352: 107-113.
22. Lim JJ, Hammoudi TM, Bratt-Leal AM, et al. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomat 2011; 7: 986-995.
23. Bhadra D, Bhadra S, Jain NK. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Pharm Res 2006; 23: 623-633.
24. Yoshihara C, Shew CY, Ito T, Koyama Y. Loosening of DNA/polycation complexes by synthetic polyampholyte to improve the transcription efficiency: effect of charge balance in the polyampholyte. Biophys J 2010; 98: 1257-1266.
25. Ito T, Iida-Tanaka N, Niidome T, et al. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release 2006; 112: 382-388.